Terns Pharmaceuticals, Inc. (TERN:NASDAQ) closed at $52.95 on May 15, 2026, down 0.03% on the day. The stock trades 0.5% below its 52-week high of $53.19 and 1,894.4% above its 52-week low of $2.66. Terns Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, TERN closed higher on 73 days (29%). Its best day was November 3, 2025 (+69.85%) and its worst was October 23, 2025 (-7.86%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
Find more stocks like TERN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.